Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis via ATF2 downregulation
Autor: | Di Zhao, Xuemeng Liu, Junhui Xing, Jie-Lei Zhang, Pengcheng Li, Jianwu Jiang, Yanzhou Zhang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
CAD coronary artery disease RIP RNA binding protein immunoprecipitation lncRNAs long noncoding RNAs ICAM-1 intercellular adhesion molecule-1 HCAECs human coronary artery endothelial cells USF1 upstream stimulatory factor 1 TNF-α tumor necrosis factor-α DMEM Dulbecco’s modified Eagle’s medium VCAM-1 vascular cell adhesion molecule 1 0302 clinical medicine HFD high fat diet ChIP Chromatin immunoprecipitation LDL low-density lipoprotein GAPDH Glyceraldehyde-3-phosphate dehydrogenase SMCs smooth muscle cells RT-qPCR reverse transcription quantitative polymerase chain reaction IL-6 interleukin-6 Gene knockdown lcsh:R5-920 Multidisciplinary ND normal diet Cell adhesion molecule Chemistry sh short hairpin RNA MCP-1 monocyte chemoattractant protein-1 030220 oncology & carcinogenesis HE Hematoxylin-eosin Tumor necrosis factor alpha medicine.symptom Hypoxia-inducible factor 1 alpha-antisense RNA 2 lcsh:Medicine (General) ECs endothelial cells ATF2 activating transcription factor 2 IL-1β interleukin-1β Intercellular Adhesion Molecule-1 IgG immunoglobulin G Inflammation Article 03 medical and health sciences CCK-8 cell counting kit-8 Activating transcription factor PBS phosphate buffered saline Downregulation and upregulation ox-LDL oxidized-low-density lipoprotein ELISA enzyme linked immunosorbent assay medicine Gene silencing Upstream transcription factor 1 lcsh:Science (General) Transcription factor HIF1A-AS2 hypoxia-inducible factor 1 alpha-antisense RNA 2 ATCC American Type Culture Collection Atherosclerosis si-NC small interfering RNA-negative control 030104 developmental biology Cancer research Long noncoding RNA lcsh:Q1-390 |
Zdroj: | Journal of Advanced Research, Vol 26, Iss, Pp 123-135 (2020) Journal of Advanced Research |
ISSN: | 2090-1232 |
Popis: | Graphical abstract The map illustrating mechanisms associated with lncRNA HIF1A-AS2-mediated inflammation in the atherosclerosis. LncRNA HIF1A-AS2 forms a complex with USF1, which is recruited into the ATF2 promoter to elevate ATF2 expression, thus promoting the development of atherosclerotic inflammation. Meanwhile, downregulation of lncRNA HIF1A-AS2 decreases the expression of ATF2 by reducing the binding of USF1 to the ATF2 promoter regions, thereby inhibiting atherosclerotic inflammation, as reflected by decreased inflammatory factors TNF-α, IL-1β and IL-6 in serum and protein levels of adhesion molecules VCAM-1, ICAM-1, and MCP-1, as well as increased cell viability and reduced apoptosis in ox-LDL-induced inflammation in ECs, SMCs, and HCAECs. Introduction In atherosclerotic lesions, extensive inflammation of the vessel wall contributes to plaque instability. Long noncoding RNAs (lncRNAs) play important roles in diverse biological processes in atherosclerosis. Objectives Here, we aim to identify the functional role and regulatory mechanisms of lncRNA hypoxia-inducible factor 1 alpha-antisense RNA 2 (HIF1A-AS2) in atherosclerotic inflammation. Methods An atherosclerotic mouse model was induced in ApoE-/- mice by high fat diet (HFD). Endothelial cells (ECs), human aortic smooth muscle cells (SMCs) or human coronary artery endothelial cells (HCAECs) were exposed to ox-LDL to develop the in vitro model. The effects of lncRNA HIF1A-AS2 on inflammation were evaluated by determining levels of inflammatory factors tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6) and levels of adhesion molecules vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and macrophage cationic peptide 1 (MCP-1). Results It was established that lncRNA HIF1A-AS2 and ATF2 were highly expressed in atherosclerotic ApoE-/- mice. Downregulating lncRNA HIF1A-AS2 in ox-LDL-exposed ECs, SMCs and HCAECs inhibited inflammation by reducing levels of pro-inflammatory factors and adhesion molecules. LncRNA HIF1A-AS2 bound to the transcription factor USF1 to elevate ATF2 expression. USF1 overexpression counteracted the suppressive effect of lncRNA HIF1A-AS2 silencing on ox-LDL-induced inflammation. Knockdown of lncRNA HIF1A-AS2 or ATF2 could also attenuate inflammation in atherosclerotic mice. Collectively, the present study demonstrates that downregulation of lncRNA HIF1A-AS2 represses the binding of USF1 to the ATF2 promoter region and then inhibits ATF2 expression, thereby suppressing atherosclerotic inflammation. Conclusion This study suggests lncRNA HIF1A-AS2 as an promising therapeutic target for atherosclerosis. |
Databáze: | OpenAIRE |
Externí odkaz: |